Participants in the post-registration clinical trials of the Russian vaccine against COVID-19 Sputnik V have already started receiving the second component of the vaccine, six people have been inoculated, Moscow Deputy Mayor Anastasia Rakova said on Wednesday, APA reports quoting Sputnik.
Moscow launched the post-registration trials on 7 September, the first participants received the vaccine on 9 September. Nineteen medical centres in the Russian capital are engaged in the studies.
"Six participants of the trials have already received the second component of the coronavirus vaccine. We plan to vaccinate around 20 people today. Sputnik V is a bicomponent vaccine, and the second inoculation is necessary to enhance the immune response obtained after the first inoculation. Following the first inoculation, which over 5,700 people have received, we see that the overwhelming majority [of those vaccinated] are feeling fine", Rakova said.